Sharon Bio-Medicine Ltd receives UKMHRA - GMP certificate for both, Tablets and Capsules

Sharon Bio-Medicine Ltd have received the certification for the approval of Good Manufacturing Practices (GMP) for both, Capsules and Tablets from United Kingdom - Medical & Health Care Product Regulatory Agency (UKMHRA) for its expanded area of Formulation and Tablets unit located at Selaqui, Uttarakhand.

In the view of the above it should be noted that after the expansion the production capacity of the Company's Formulation and Tablets plant located at Selaqui, Uttarakhand has been doubled in the term of production.

Shares of SHARON BIO-MEDICINE LTD. was last trading in BSE at Rs.22.05 as compared to the previous close of Rs. 20.05. The total number of shares traded during the day was 341740 in over 2851 trades.

The stock hit an intraday high of Rs. 22.05 and intraday low of 18.5. The net turnover during the day was Rs. 7136814.

Source : Equity Bulls

Keywords